Hyalinizing trabecular adenoma (HTA) is a very rare tumor (<1% of all primary thyroid gland tumors) of thyroid follicular cell origin with a trabecular pattern of growth and marked intratrabecular hyalinization (fi gure 1). For all intents and purposes, this is a benign tumor, although there is a case report of pulmonary metastasis with invasion, suggesting the term tumor be used instead of adenoma. A few cases have occurred following radiation exposure, and there may be a relationship to thyroid papillary carcinoma, as there have been reports of RET/ PTC rearrangements.
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Most patients with HTA are middle-aged (mean, 50 years), and this tumor has a female predominance (female-to-male, 6:1). Patients are usually asymptomatic, with a mass found incidentally during a routine physical exam.
Conservative but complete excision (lobectomy) yields a cure in nearly all cases. Ultrasonography typically shows a solid nodule with hypoechoic or heterogeneous echogenicity.
Th e tumors are usually small (mean, 2.5 cm), solitary, solid, encapsulated masses, with a lobulated, yellowtan cut surface showing patulous vessels and rare calcifi cations. Th e circumscribed tumors are surrounded by a thin, irregular, and uneven fi brous connective-tissue capsule. Th e cellular tumors are arranged in trabecular, alveolar, or insular growth patterns. Th e trabeculae are straight to curvilinear groups of cells, 2 to 4 cells thick. Th ere is scant to absent colloid.
Th e medium to large, polygonal to fusiform cells contain oval to elongated nuclei arranged perpendicular to the long axis of the trabeculae and fi brovascular stroma. Th e nuclei show prominent grooves, contour irregularities, and intranuclear cytoplasmic inclusions. Perinucleolar halos are also seen. Th e cytoplasm is homogeneous, glassy to granular, occasionally containing distinctive round, refractile, paranuclear yellow bodies or vacuoles. Th e tumor cells are surrounded by dense, intratrabecular, heavily hyalinized, eosinophilic fi brovascular stroma, which spills out into the intertrabecular zones. Th e hyalinization shows zonation, with greater deposition at the periphery of the trabeculae. Calcospherites (psammoma or calcifi c bodies) may be seen. Mitoses are rare.
Th e neoplastic cells show strong and well-developed positive reactions with thyroglobulin, TTF-1, keratin, and CK7. A unique membranous and cytoplasmic reaction with Ki-67 (Dako MIB1 antibody) is diff erent from the usual nuclear reaction with this antibody (fi gure 2). No BRAF or RAS mutations are identifi ed in this tumor. Th e diff erential diagnosis includes thyroid papillary carcinoma (there is usually invasive growth; very rare to have extensive intratrabecular stromal hyalinization; yellow bodies are not present; MIB1 membra-nous reaction is absent), follicular adenoma or carcinoma (there can be intertrabecular hyalinization, but usually no intratrabecular hyalinization; yellow bodies are absent; perpendicular nuclear arrangement is usually absent; MIB1 membranous reaction is absent), medullary thyroid carcinoma (an invasive tumor that lacks colloid; amyloid is unique; shows calcitonin and chromogranin immunoreactivity) and, rarely, paraganglioma (may have a similar growth pattern, but the strong chromogranin and/or synaptophysin reaction with S-100 protein sustentacular reaction will help with classifi cation). 
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